Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check4 days agoChange DetectedThe 403 error page now displays an NIH notice about terminology changes during its website transition, and the site revision advances to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov site footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedStudy record page now displays a 403 Forbidden error, replacing the previously visible study details and related content. This blocks access to the trial's core information including objectives, eligibility criteria, and locations.SummaryDifference21%

- Check39 days agoChange DetectedThe revision tag on the page has been updated to v3.7.0, replacing the previous v3.6.6. This denotes a newer documentation version but does not change the study details or data.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling that a new build of the page was released.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page gained an NIH funding note—'2018 ( U.S. NIH Grant/Contract )'—added next to the EudraCT number in the Study Details area, documenting the U.S. funding source for the trial.SummaryDifference0.0%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.